Alopecia (Hair Loss) Treatment Market Analysis & Forecast 2024-2030

Alopecia (Hair Loss) Treatment Market by Treatment Types ( Hair growth devices, Shampoos and Conditioners, Medicines) by Applications (Homecare, Salons, Dermatology clinics) by Industry Analysis, Volume, Share, Consumer Insight, Challenges, Trends, Strategies & Forecast 2024-2030, Regional Outlook ( North America, Europe, Asia-Pacific, Middle-East, Africa)

Report Code: PSMR- 500715          Category: Healthcare          Region :  Global         Report Format :                  

 Request Free Sample


     Table of Contents

    Global Alopecia (Hair Loss) Treatment Market is expected to reach USD 4769.12 million by 2030 with CAGR of 5.5% between 2024 and 2030


    Alopecia is a common hair fall disease that affects men as well as women. Alopecia leads to progressive thinning of the scalp hair in small patches. There is no current cure for alopecia but several treatment options are available in the market to regrow hair with varying effectiveness depending on the severity of the disease. The growing prevalence of alopecia around the world is the major driver for the growth of the Global Alopecia (Hair Loss) Treatment Market. Improvements in the development and manufacturing of both herbal drugs (natural) and synthetic drugs to control the hair fall and hair growth with lesser side effects, adverse drug reaction, and improved patient compliance are expected to offer several growth opportunities in the forecast period.  

    Alopecia (Hair Loss) Treatment Market

    Treatment types & Competitive analysis

    Global Alopecia (Hair Loss) Treatment Market is segmented into hair growth devices, shampoos and conditioners, and medicines. Medicines segment led the Global Alopecia (Hair Loss) Treatment Market accounting for the largest revenue market share in 2023. Shampoos and conditioners are the fastest growing treatment segment in 2023 and are growing at a significant pace in the last few years due to the growing demand for over-the-counter and prescription-based ketoconazole shampoos and conditioners to prevent damage and hair loss. These products have gained popularity among consumers and are beneficial to promote the growth and strength of hair. Increasing the number of brands in the market with new offerings such as products with lesser parabens, sulfate is expected to boost the growth of the shampoos and conditioners segment in the forecast period.  

    Competitive analysis included in research study helps users to understand key players market positioning and marketing strategies. Technological advancements in alopecia treatments are offering lucrative opportunities for the key stakeholders in the market. Several companies are offering various kinds of topical products, medicines, injectable therapies, and devices to treat hair loss. These are showing promising results in both men and women. The majority of companies are located in North America and the European region.  

    Several players are getting their products approved through the FDA (Food and Drug Administration) regulatory boards. For instance, in June 2020 Follica Biopharmaceutical Company developing a regenerative platform to treat androgenetic alopecia, epithelial aging, and other related conditions has received a positive response from their 2nd clinical trial and are moving to its phase 3 trials. Products produced from organic ingredients are gaining prominence in the market. For instance, polyherbal treatments that include more than one herb are getting popular in the markets which offer superior hair fall treatment. 

    Minoxidil is one of the effective hair growth stimulants it is being used to reduce hair fall and maintain hair growth in several medications. Moreover, companies are also expanding their presence across developing countries to create a loyal customer base. In October 2020 LG’s beauty products division-Pra.L launched a new FDA-approved MediHair which helps in hair growth. It uses low-level light therapy (LLLT) to stimulate hair growth. Low-level light therapy has been permitted by the FDA (Food and Drug Administration) as a treatment for Androgenetic alopecia which is a very common type of male baldness. LG claims that using LG Pra.L MediHair three times a week for 16 weeks increases hair density and thickness.  

    Alopecia (Hair Loss) Treatment Market

    Application & Regional analysis

    On the basis of applications Global Alopecia (Hair Loss) Treatment Market is divided into Homecare, Salons, and Dermatology clinics. The dermatology clinics segment is projected to account for the largest share in the market during the forecast period 2023-2029. Increasing awareness regarding the presence and benefits of new hair care treatments especially among youngsters and adults is driving the growth of the dermatology clinics segment. Moreover, increased access to dermatology services around the world, rising disposable income, growing desire to look good is expected to drive the growth of the dermatology clinics segment in the foreseeable future.  

    Regional outlook of research study is based on analysis of market in North America, Europe, Asia Pacific, Middle East, South America, and Africa & Rest of the World. North America led the Global Alopecia (Hair Loss) Treatment Market in 2023. The rising burden of alopecia, rising sedentary lifestyle, presence of sophisticated healthcare facilities, and faster adoption of new treatments and therapies for alopecia are some key driving factors for the growth in the North America Alopecia (Hair Loss) Treatment Market. The U.S. was the largest market in North America in terms of revenue generation and is one of the largest markets in the world. According to the National Alopecia Areata Foundation alopecia affects about 6.8 million people in the U.S. Asia Pacific was the fastest-growing region and is expected to grow at the highest CAGR in the forecast period 2023-2029.  

    The growth in the Asia Pacific region was primarily driven by the rising prevalence of alopecia, growing awareness, rising disposable income, and booming dermatology industry. Androgenetic alopecia is very common in Asian people. The prevalence rate of the disease varies from country to country and is generally found in countries such as China, India, South Korea, and Japan. The European market is expected to grow at a significant rate owing to increased consumption of tobacco, growing stress among people resulting in a significant rise in disease burden.  

    Global Alopecia (Hair Loss) Treatment Market : Treatment Types

    • Hair growth devices
    • Shampoos and Conditioners
    • Medicines

    Global Alopecia (Hair Loss) Treatment Market : Applications

    • Homecare
    • Salons
    • Dermatology clinics

    Global Alopecia (Hair Loss) Treatment Market : Competitive Analysis

    Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study constitutes of following key players in Global Alopecia (Hair Loss) Treatment Market :

    • Cipla Ltd.
    • Johnson & Johnson, Inc.
    • Dr. Reddy’s Laboratories Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Merck & Co., Inc.
    • Taisho Pharma

    Geographical analysis of Global Alopecia (Hair Loss) Treatment Market :

    • North America
      • U.S.A
      • Canada
    • Europe
      • France
      • Germany
      • Spain
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South East Asia
    • Latin America
      • Brazil
    • Middle East and Africa

    Global Alopecia (Hair Loss) Treatment Market Report delivers a comprehensive analysis of the following parameters:

    • Market Forecast for 2024-2030
    • Market growth drivers
    • Challenges and Opportunities
    • Emerging and Current market trends
    • Market player Capacity, Production, Revenue (Value)
    • Supply (Production), Consumption, Export, Import analysis
    • End user/application Analysis

    Report Coverage

    Parameters Details

    Base Year


    Historical Data


    Forecast Data


    Base Year Value (2023)

    USD 3107.55 million

    Forecast Value (2030)

    USD 4769.12 million

    CAGR (2022 to 2028)

    5.5 %

    Regional Scope

    North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW

    Frequently Asked Questions (FAQ)

    Alopecia (Hair Loss) Treatment Market was valued at around USD 3107.55 million in 2023 & estimated to reach USD 4769.12 million by 2030.

    Alopecia (Hair Loss) Treatment Market is likely to grow at compounded annual growth rate (CAGR) of 5.5% between 2024 to 2030.

    Shampoos and conditioners segment dominates the market in terms of revenue generation. North America region is likely to show the highest growth rate between 2024 to 2030.

    Some of the top companies included in the research report are Cipla Ltd. Johnson & Johnson, Inc., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Taisho Pharma.

    The growing prevalence of alopecia around the world is the major driver for the growth of the Global Alopecia (Hair Loss) Treatment Market.

    Yes, the report includes COVID 19 impact on the market.

    Purchase Options

      Online Access $2450

      PDF Access $3550

      PDF + Dashboard $4050

    Inquire Before Buying

    Please fill below details:

      Free Customization

      We are committed to offering 100 % free customization while purchasing.

        Access the FREE Sample

        Receive a detailed insight into the Alopecia (Hair Loss) Treatment Market research study with our FREE sample report delivered straight to your email. The report covers major market factors such as Revenue, Forecast, Top companies insight, Regional analysis, Market trends & more.

         Request Free Sample